| Modelling the impact of hybrid immunity on future COVID-19 epidemic waves TP Le, I Abell, E Conway, PT Campbell, AB Hogan, MJ Lydeamore, ... BMC Infectious Diseases 24 (1), 1-14, 2024 | 1 | 2024 |
| SARS-CoV-2 infection rates and associated risk factors in healthcare settings: systematic review and meta-analysis A Bansal, MC Trieu, EM Eriksson, F Zhou, J McVernon, KA Brokstad, ... | | 2024 |
| Genomic surveillance of invasive meningococcal disease during a national MenW outbreak in Australia, 2017–2018 E Sotheran, CR Lane, K Horan, K Stevens, C Guglielmino, S Bradbury, ... Open Forum Infectious Diseases 11 (6), 2024 | | 2024 |
| Estimating the impact of test–trace–isolate–quarantine systems on SARS-CoV-2 transmission in Australia FM Shearer, JM McCaw, GE Ryan, T Hao, NJ Tierney, MJ Lydeamore, ... Epidemics 47, 100764, 2024 | 7 | 2024 |
| Estimating measures to reduce the transmission of SARS-CoV-2 in Australia to guide a ‘National Plan’to reopening GE Ryan, FM Shearer, JM McCaw, J McVernon, N Golding Epidemics 47, 100763, 2024 | 6 | 2024 |
| One Health pandemic preparedness: the role of companion animals in disease transmission AJ Marcato, N Meagher, V Spirkoska, A Arnott, J McVernon, DJ Price, ... Lancet (London, England) 403 (10440), 1984-1985, 2024 | | 2024 |
| Erratum to “Learnings from the Australian first few X household transmission project for COVID-19”[The Lancet Regional Health–Western Pacific 28 (2022) 100573] AJ Marcato, AJ Black, CR Walker, D Morris, N Meagher, DJ Price, ... The Lancet Regional Health–Western Pacific 46, 2024 | | 2024 |
| Burden of antimicrobial prescribing in primary care attributable to sore throat: a retrospective cohort study of patient record data KS Carville, N Meagher, YN Abo, JA Manski-Nankervis, J Fielding, ... BMC Primary Care 25 (1), 117, 2024 | | 2024 |
| Moving cholera vaccines ahead of the epidemic curve ZA Memish, L Blumberg, AS Al-Maani, R Baru, E Dube, GF Gao, ... The Lancet 403 (10422), 127-129, 2024 | | 2024 |
| Optimal timing of booster doses in a highly vaccinated population with minimal natural exposure to COVID-19 E Conway, C Walker, M Lydeamore, N Golding, G Ryan, D Mavec, ... medRxiv, 2024.05. 14.24307386, 2024 | | 2024 |
| Quantifying the impact of contact tracing interview prioritisation strategies on disease transmission LB Wu, CB Baker, N Tierney, K Carville, J McVernon, J McCaw, N Golding, ... medRxiv, 2024.04. 30.24306519, 2024 | | 2024 |
| Border quarantine, vaccination and public health measures to mitigate the impact of COVID-19 importations: a modelling study MJ Lydeamore, C Zachreson, E Conway, FM Shearer, C Baker, J Ross, ... medRxiv, 2024.04. 22.24305704, 2024 | | 2024 |
| A model-based assessment of social isolation practices for COVID-19 outbreak response in residential care facilities C Zachreson, R Tobin, C Walker, E Conway, FM Shearer, J McVernon, ... arXiv preprint arXiv:2401.01371, 2023 | | 2023 |
| Seasonality as a driver of pH1N12009 influenza vaccination campaign impact KJ Bolton, JM McCaw, MP Dafilis, J McVernon, JM Heffernan Epidemics 45, 100730, 2023 | | 2023 |
| Having a real say: findings from first nations community panels on pandemic influenza vaccine distribution K Crooks, K Taylor, K Burns, S Campbell, C Degeling, J Williams, ... BMC public health 23 (1), 2377, 2023 | | 2023 |
| Individual level analysis of digital proximity tracing for COVID-19 in Belgium highlights major bottlenecks C Geenen, J Raymenants, S Gorissen, J Thibaut, J McVernon, N Lorent, ... Nature Communications 14 (1), 6717, 2023 | 1 | 2023 |
| Rapid prototyping of models for COVID-19 outbreak detection in workplaces I Abell, C Zachreson, E Conway, N Geard, J McVernon, T Waring, C Baker BMC Infectious Diseases 23 (1), 713, 2023 | | 2023 |
| COVID-19 vaccine coverage targets to inform reopening plans in a low incidence setting E Conway, CR Walker, C Baker, MJ Lydeamore, GE Ryan, T Campbell, ... Proceedings of the Royal Society B 290 (2005), 20231437, 2023 | 9 | 2023 |
| Evaluating the role of asymptomatic throat carriage of Streptococcus pyogenes in impetigo transmission in remote Aboriginal communities in Northern Territory, Australia: a … JA Lacey, AJ Marcato, RH Chisholm, PT Campbell, C Zachreson, ... The Lancet Microbe 4 (7), e524-e533, 2023 | 11 | 2023 |
| SARS-CoV-2 seroepidemiology in Mongolia, 2020–2021: a longitudinal national study B Chimeddorj, CR Bailie, U Mandakh, DJ Price, B Bayartsogt, N Meagher, ... The Lancet Regional Health–Western Pacific 36, 2023 | 4 | 2023 |
